 | • レポートコード：MRC-IM30205 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界のモノクローナル抗体市場規模は2021年に1,940.3億ドルに達しました。今後、2027年には3,041.6億ドルになり、2022年から2022年の間に年平均8.10％成長すると予測しています。本調査レポートでは、モノクローナル抗体の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、製法別（インビボ、インビトロ）分析、ソース別（ネズミ、キメラ、ヒト化、人間）分析、疾患別（癌、自己免疫疾患、炎症性疾患、感染症、その他）分析、エンドユーザー別（病院、研究機関、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界のモノクローナル抗体市場規模：製法別 - インビボモノクローナル抗体の市場規模 - インビトロモノクローナル抗体の市場規模 ・世界のモノクローナル抗体市場規模：ソース別 - ネズミにおける市場規模 - キメラにおける市場規模 - ヒト化における市場規模 - 人間における市場規模 ・世界のモノクローナル抗体市場規模：疾患別 - 癌における市場規模 - 自己免疫疾患における市場規模 - 炎症性疾患における市場規模 - 感染症における市場規模 - その他疾患における市場規模 ・世界のモノクローナル抗体市場規模：エンドユーザー別 - 病院における市場規模 - 研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界のモノクローナル抗体市場規模：地域別 - 北米のモノクローナル抗体市場規模 - アジアのモノクローナル抗体市場規模 - 欧州のモノクローナル抗体市場規模 - 中南米のモノクローナル抗体市場規模 - 中東・アフリカのモノクローナル抗体市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global monoclonal antibodies market size reached US$ 194.03 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 304.16 Billion by 2027, exhibiting a growth rate (CAGR) of 8.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targetting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells.
Monoclonal Antibodies Market Trends:
At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer’s, Huntington’s, Parkinson’s, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global monoclonal antibodies market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on production method, source, indication and end use.
Breakup by Production Method:
In Vivo
In Vitro
Breakup by Source:
Murine
Chimeric
Humanized
Human
Breakup by Indication:
Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Others
Breakup by End Use:
Hospitals
Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global monoclonal antibodies market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global monoclonal antibodies market?
What are the key regional markets?
What is the breakup of the market based on the production method?
What is the breakup of the market based on the source?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global monoclonal antibodies market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Monoclonal Antibodies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Production Method
6.1 In Vivo
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 In Vitro
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Source
7.1 Murine
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chimeric
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Humanized
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Human
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Indication
8.1 Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Inflammatory Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Infectious Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End Use
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Biogen Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 GSK plc
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2021
Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2021
Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2021
Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2021
Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2021
Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis